ArticlebioRxiv : the preprint server for biology2025
Systematic pre-annotation explains the "dark matter" in LC-MS metabolomics.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
Abstract
The majority of features in global metabolomics from high-resolution mass spectrometry are typically not identified, referred as the "dark matter". Are these features real compounds or junk? Understanding this problem is critical to the annotation and interpretation of metabolomics data and future development of the field. Recent debates also brought attention to in-source fragments, which appear to be prevalent in spectral databases. We report here a systematic analysis of 61 representative public datasets from LC-MS metabolomics, the most common data type in biomedical studies. The results indicate that in-source fragments contribute to less than 10% of features in LC-MS metabolomics. Khipu-based pre-annotation shows that majority of abundant features have identifiable ion patterns. This suggests that the "dark matter" in LC-MS metabolomics is explainable in an abundance dependent manner; most features are from real compounds; the number of compounds is much smaller than that of features; most compounds are yet to be identified.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.